Intended for healthcare professionals

  1. Research
  2. Analysis and...
  3. Analysis and interpretation of cost data in randomised controlled trials: review of published studies
Papers

Analysis and interpretation of cost data in randomised controlled trials: review of published studies

BMJ 1998; 317 doi: https://doi.org/10.1136/bmj.317.7167.1195 (Published 31 October 1998) Cite this as: BMJ 1998;317:1195

Related articles

See more

Cited by...

  • Evaluating the impact of a common elements-based intervention to improve maternal psychological well-being and mother-infant interaction in rural Pakistan: study protocol for a randomised controlled trial
  • Cost of maternal health services in low and middle-income countries: protocol for a systematic review
  • Clinical and cost-effectiveness of adapted cognitive behaviour therapy for non-cardiac chest pain: a multicentre, randomised controlled trial
  • The economic effects of supporting tuberculosis-affected households in Peru
  • Impact of personality status on the outcomes and cost of cognitive-behavioural therapy for health anxiety
  • The clinical and cost-effectiveness of brief advice for excessive alcohol consumption among people attending sexual health clinics: a randomised controlled trial
  • Documenting the Benefits and Cost Savings of a Large Multistate Cancer Pathway Program From a Payer's Perspective
  • Economic evaluation within a factorial-design randomised controlled trial of exercise, manual therapy, or both interventions for osteoarthritis of the hip or knee: study protocol
  • Cost Effectiveness of Warfarin Versus Aspirin in Patients Older Than 75 Years With Atrial Fibrillation
  • Cost Savings with Rapid Diagnostic Tests for Malaria in Low-Transmission Areas: Evidence from Dar es Salaam, Tanzania
  • Economic evaluation of nurse practitioners versus GPs in treating common conditions
  • Cost-effectiveness of selective serotonin reuptake inhibitors and routine specialist care with and without cognitive behavioural therapy in adolescents with major depression
  • Economic evaluation of a randomised controlled trial for anorexia nervosa in adolescents
  • Patient self management of oral anticoagulation in routine care in the UK
  • Comparison of rHuEpo plus rHuG-CSF and supportive care: apples to oranges
  • Health, economic, and quality-of-life effects of erythropoietin and granulocyte colony-stimulating factor for the treatment of myelodysplastic syndromes: a randomized, controlled trial
  • Meta-analysis of data on costs from trials of counselling in primary care: using individual patient data to overcome sample size limitations in economic analyses
  • Being economical with the truth: how to make your idea appear cost effective
  • Cost effectiveness of continuing professional development in health care: a critical review of the evidence
  • Cost of Identifying Patients for Carotid Endarterectomy
  • Costs and Benefits of Carotid Endarterectomy and Associated Preoperative Arterial Imaging: A Systematic Review of Health Economic Literature
  • Factors that influence the cost of caring for patients with severe psychotic illness: Report from the UK 700 trial
  • Randomised controlled trial of non-directive counselling, cognitive-behaviour therapy, and usual general practitioner care for patients with depression. II: Cost effectiveness
  • Randomised comparison of the effectiveness and costs of community and hospital based mental health services for children with behavioural disorders
  • The London Depression Intervention Trial: Randomised controlled trial of antidepressants v. couple therapy in the treatment and maintenance of people with depression living with a partner: clinical outcome and costs
  • Open access follow up for inflammatory bowel disease
  • Cost-effectiveness of intensive v. standard case management for severe psychotic illness: UK700 case management trial
  • How should cost data in pragmatic randomised trials be analysed?
  • Cost analysis of nurse telephone consultation in out of hours primary care: evidence from a randomised controlled trial
  • Randomised controlled trial comparing cost effectiveness of general practitioners and nurse practitioners in primary care
  • Importance of health economics must be recognised when trials are designed
Back to top